Miron Prokocimer
Impact in
- Hematology top 2%
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
- Genetics top 2%
- Chronic Lymphocytic Leukemia Research
Papers in
- Hematology 22
- Chronic Myeloid Leukemia Treatments 11
- Acute Myeloid Leukemia Research 7
- Genetics 18
- Chronic Lymphocytic Leukemia Research 16
- Co-authors
- Varda Rotter (14 shared papers)Yosef Gruenbaum (5 shared papers)D. Wolf (4 shared papers)Aaron Polliack (6 shared papers)Alina Molchadsky (1 shared paper)Ayelet Margalit (2 shared papers)H. Phillip Koeffler (2 shared papers)Mati Shaklai (12 shared papers)
- Journals
- Blood (9 papers)Postgraduate Medical Journal (7 papers)American Journal of Hematology (3 papers)Cancer (3 papers)Genes Chromosomes and Cancer (2 papers)
- Partner nations
- IsraelUnited StatesTürkiye
In The Last Decade
Miron Prokocimer
59 papers receiving 2.2k citations
Peers
Comparison fields: 5 of 93
- Hematology 510
- Genetics 322
- Oncology 794
- Biotechnology 182
- Molecular Biology 1.2k
Countries citing papers authored by Miron Prokocimer
This map shows the geographic impact of Miron Prokocimer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Miron Prokocimer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Miron Prokocimer more than expected).
Fields of papers citing papers by Miron Prokocimer
This network shows the impact of papers produced by Miron Prokocimer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Miron Prokocimer. The network helps show where Miron Prokocimer may publish in the future.
Co-authors
The 25 scholars most cited alongside Miron Prokocimer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 60 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 218 | |
| 2 | 2003 | 193 | |
| 3 | 1986 | 190 | |
| 4 | 1994 | 151 | |
| 5 | 1986 | 140 | |
| 6 | 1989 | 138 | |
| 7 | 2017 | 127 | |
| 8 | 1994 | 127 | |
| 9 | 1998 | 118 | |
| 10 | 1986 | 85 | |
| 11 | 1981 | 73 | |
| 12 | 2013 | 69 | |
| 13 | 2006 | 58 | |
| 14 | 1986 | 51 | |
| 15 | 1980 | 39 | |
| 16 | 1991 | 36 | |
| 17 | 2001 | 31 | |
| 18 | 2003 | 31 | |
| 19 | 1997 | 31 | |
| 20 | 2006 | 25 |
About Miron Prokocimer
Miron Prokocimer is a scholar working on Hematology, Genetics, Molecular Biology, Oncology and Pathology and Forensic Medicine, having authored 60 papers that have together received 2.3k indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (16 papers), Cancer-related Molecular Pathways (12 papers), Chronic Myeloid Leukemia Treatments (11 papers), Lymphoma Diagnosis and Treatment (8 papers), Acute Myeloid Leukemia Research (7 papers), RNA Research and Splicing (5 papers), Eosinophilic Disorders and Syndromes (5 papers) and Nuclear Structure and Function (5 papers). The work is most often cited by research in Hematology (510 citations), Genetics (322 citations), Oncology (794 citations), Biotechnology (182 citations) and Molecular Biology (1.2k citations). Miron Prokocimer has collaborated with scholars based in Israel, United States and Türkiye. Frequent co-authors include Varda Rotter, Yosef Gruenbaum, D. Wolf, Aaron Polliack, Alina Molchadsky, Ayelet Margalit, H. Phillip Koeffler, Mati Shaklai, T. Mohandas and Carl W. Miller. Their work appears in journals such as Blood, Postgraduate Medical Journal, American Journal of Hematology, Cancer and Genes Chromosomes and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.